Martina Slingsby
Analyst
Senior Clinical Scientist and ALN 6400 Clinical Science Lead
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Martina Slingsby
Martina Slingsby is recorded as Analyst at Senior Clinical Scientist and ALN 6400 Clinical Science Lead. Martina Slingsby has spoken on 2 investor events across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on June 9, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Senior Clinical Scientist and ALN 6400 Clinical Science Lead
Analyst
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.